Evidence map›Paper›PMID 21454423›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2011

Vitamin D: marker or mechanism of action?

Elizabeth T Jacobs, María Elena Martínez, Peter W Jurutka

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Vitamin D: A Bridge between Kidney and Heart.Life (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elizabeth T JacobsArizona Cancer Center, University of Arizona, P.O. Box 245024, 1515 N Campbell Ave, Tucson, AZ 85724-5024, USA. jacobse@email.arizona.edu
María Elena Martínez
Peter W Jurutka
University of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
WHEAT BRAN FIBER SUPPLEMENTS ON THE RECURRENCE OF COLONIC ADENOMASP01CA041108 · NCI · UNIVERSITY OF ARIZONA · PI LANCE, M. PETER · 1986 to 2009
$38.8M
SPORE in Gastrointestinal CancerP50CA095060 · NCI · UNIVERSITY OF ARIZONA · PI GERNER, EUGENE W · 2002 to 2012
$25.3M
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and RiR01CA140285 · NCI · UNIVERSITY OF ARIZONA · PI JACOBS, ELIZABETH T, JURUTKA, PETER W · 2010 to 2014
$1.5M
VDR Variants, Nutrient Intakes, and Adenoma RecurrenceK07CA106269 · NCI · UNIVERSITY OF ARIZONA · PI JACOBS, ELIZABETH T · 2005 to 2009
$665k
SERUM SELENIUM AND LARGE BOWEL ADENOMA RISKR03CA077145 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1997 to 1998
–
NCI NIH HHS CA140285NCI NIH HHS CA23074NCI NIH HHS CA77145NCI NIH HHS CA95060NCI NIH HHS K07 CA106269NCI NIH HHS K07CA106269NCI NIH HHS P01 CA041108NCI NIH HHS P01CA41108NCI NIH HHS P30 CA023074NCI NIH HHS P50 CA095060NCI NIH HHS R01 CA140285
6 · The paper itself

Abstract

The field of vitamin D and cancer research has been moving forward quickly. However, some challenges remain regarding the interpretation and integration of data collected from epidemiological investigations and laboratory experiments. These include consideration of vitamin D biology, a better understanding of characteristics that affect concentrations of the biomarker of vitamin D status, 25(OH)D, and elucidation of variation in response to vitamin D supplementation. To further the field of vitamin D and cancer prevention, future studies will need to bridge the gap between the epidemiology and molecular biology of vitamin D activity in carcinogenesis.

Indexed as

Anticarcinogenic AgentsBiomarkers, TumorHumansNeoplasmsRisk FactorsVitamin DAnticarcinogenic AgentsBiomarkers, TumorVitamin D

Identifiers

PMID21454423
PMCPMC3074255
OpenAlexW2097271560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.